0 Comments
0 Shares
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Neoantigen Targeted Therapies Market is estimated to be worth USD 3 Billion in 2030Advances in bioinformatics and genomic data analysis have enabled the identification of cancer antigens that are generally overlooked during immune surveillance; these neoantigens have been shown to possess substantial therapeutic potential Roots Analysis is pleased to announce the publication of its recent study, titled, “Neoantigen Targeted Therapies Market, 2021-2030.” The report...0 Comments 0 Shares
-
Neoantigen Targeted Therapies Market is estimated to be worth USD 3 Billion in 2030Advances in bioinformatics and genomic data analysis have enabled the identification of cancer antigens that are generally overlooked during immune surveillance; these neoantigens have been shown to possess substantial therapeutic potential Roots Analysis is pleased to announce the publication of its recent study, titled, “Neoantigen Targeted Therapies, 2019-2030.” The report...0 Comments 0 Shares
-
The CAR-T therapies market is characterized by a healthy pipeline of promising therapiesGiven the success of approved CAR-T cell therapies, such as KYMRIAH®, YESCARTA®, TECARTUS® and BREYANZI®, this upcoming class of biologics are anticipated to carve out a significant share of the multi-billion dollar cancer immunotherapy market Roots Analysis has announced the addition of “CAR-T Cell Therapies Market (3rd Edition) by Target Indications (NHL, Multiple...0 Comments 0 Shares
-
The CAR-T therapies market is characterized by a healthy pipeline of promising therapies, claims Roots AnalysisReport Keywords - CAR-T Cell, Therapies Market, Rootsanalysis, Report, Biotech Given the success of approved CAR-T cell therapies, such as KYMRIAH®, YESCARTA®, TECARTUS® and BREYANZI®, this upcoming class of biologics are anticipated to carve out a significant share of the multi-billion dollar cancer immunotherapy market Roots Analysis has announced the addition of...0 Comments 0 Shares
-
The non-hormonal therapies market is growing at an annualized rate of 21.7%, claims Roots AnalysisDriven by the potential to confer safe and sustained therapeutic effects for clinical conditions unique to women, the non-hormonal therapies pipeline is growing, featuring candidates having improved risk profiles and lesser side effects Roots Analysis has announced the addition of “Non-hormonal Therapies for Women’s Health Market 2021 – 2030” report to its...0 Comments 0 Shares
-
The TIL-based therapies market is projected to be worth over USD 4.3 billion, by 2030, claims Roots AnalysisDriven by the potential to confer sustained therapeutic effects and thereby, facilitate prolonged periods of remission, TIL-based therapies have received significant financial support, and promising leads are poised to soon achieve blockbuster status Roots Analysis has announced the addition of “TIL-based Therapies Market, 2021-2030” report to its list of offerings. ...0 Comments 0 Shares
-
TIL-based Therapies Market, 2021-2030 by Roots AnalysisDriven by the potential to confer sustained therapeutic effects and thereby, facilitate prolonged periods of remission, TIL-based therapies have received significant financial support, and promising leads are poised to soon achieve blockbuster status Roots Analysis has announced the addition of “TIL-based Therapies Market, 2021-2030” report to its list of offerings. ...0 Comments 0 Shares
-
What Are the Projected Growth Rates for Different Types of Pain Management Therapies in 2024?The pain management market is expected to experience significant growth in 2024, with various therapies contributing to this upward trend. According to the latest market report by MRFR, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) will continue to dominate due to their widespread use in treating pain and inflammation. Additionally, anticonvulsants are increasingly...0 Comments 0 Shares
-
With over 280 therapies under evaluation, the stem cell therapy market is estimated to be worth USD 8.5 Billion by 2030, claims Roots AnalysisWith multiple approved products, the field of stem cell therapies has gained substantial momentum over the last decade; several innovator companies are currently progressing their proprietary therapy candidates with cautious optimism. In fact, recent studies suggest that mesenchymal stem cells have the potential to end the Coronavirus (COVID-19) pandemic. Roots Analysis is pleased to...0 Comments 0 Shares
-
What is LENS? How can it work for me?LENS – or Low Energy Neurofeedback System– is an advanced form of brain technology or EEG biofeedback for adults and children – so-called, because it uses a tiny signal, hundreds of times smaller than your cell phone, that your brain is attracted to, and which enables it to reboot and reset in a beneficial way to optimize function. For those suffering from Anxiety, Depression,...0 Comments 0 Shares
More Results